Cellcept and Retinal vasculitis - a phase IV clinical study of FDA data

Summary:

Retinal vasculitis is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are female, 40-49 old, also take Inflectra, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Retinal vasculitis when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Retinal vasculitis?

Retinal vasculitis (a sight-threatening inflammatory eye condition that involves the retinal vessels) is found to be associated with 67 drugs and 146 conditions by eHealthMe. Check the latest studies of Retinal vasculitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 11 people (0.03%) have Retinal vasculitis.

Could Cellcept cause Retinal vasculitis?

Among these 11 people:

What is the gender of people who have Retinal vasculitis when taking Cellcept? *

female: 80 %
male: 20 %

What is the age of people who have Retinal vasculitis when taking Cellcept? *

What are other drugs people take besides Cellcept? *

What are other side effects people have besides Retinal vasculitis? *

Migraine (headache): 7 people, 63.64%
Cataract (clouding of the lens inside the eye): 7 people, 63.64%
Acne (skin problems that cause pimples): 6 people, 54.55%
Blood Creatinine Increased: 6 people, 54.55%
Depression: 6 people, 54.55%
Dizziness: 6 people, 54.55%
Drowsiness: 6 people, 54.55%
Food Poisoning (poison in food): 6 people, 54.55%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 6 people, 54.55%
Otitis (ear infection): 6 people, 54.55%

What are the existing conditions these people have? *

Pain: 6 people, 54.55%
Nausea (feeling of having an urge to vomit): 6 people, 54.55%
Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 54.55%
Uveitis (inflammation of the uvea): 5 people, 45.45%
High Blood Cholesterol: 4 people, 36.36%
Thyroid Diseases: 3 people, 27.27%
Stress And Anxiety: 3 people, 27.27%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 27.27%
Neurosarcoidosis (a condition of unknown cause featuring a collection of immune cells in various tissues, involving the central nervous system (brain and spinal cord)): 3 people, 27.27%
Hypersensitivity: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Retinal vasculitis?

- Check whether Retinal vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal vasculitis:

Retinal vasculitis (67 drugs)

Browse all the conditions that are associated with Retinal vasculitis:

Retinal vasculitis (146 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.